Fleury company profile

FLRY3 · B3 · BRL

Compare Fleury
R$21.51Change from previous close: 0.00%

Close · November 22, 2026

Company profile

Fleury has 32,000 employees and is headquartered in São Paulo, Brazil.

Diagnostic Medicine, one of the two segments of Fleury S.A. and its subsidiaries, centers on diagnostic imaging and clinical analysis, alongside fertility services and infusions, all provided in Brazil. The second segment, Integrated Medicine, groups medical services that include laboratory support, health management, orthopedics, ophthalmology, toxicological tests and assistance medicine. The group also runs a health platform, an immunobiological drug infusion center and ophthalmology service centers.

In the fiscal year ended 31 December 2025, Fleury reported revenue of BRL 8.3 billion, up 7.9% from the previous year, and net income of BRL 612.8 million. The company employs 32,000 people and is headquartered in São Paulo, where it was founded in 1926.

Company facts

Industry
Diagnostics & Research
Country
Brazil
Headquarters
Avenida Morumbi, 04703-003, São Paulo
Employees
32,000
Chief executive
Jeane Tsutsui
Founded
1926
Fiscal year
January - December
Listing
FLRY3 · B3
Indices
Ibovespa
Currency
BRL
ISIN
BRFLRYACNOR5

Fleury and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
FleuryFLRY3Brazil$1.97B32,00016.0%15.0
Diagnosticos da AmericaDASA3Brazil$686.17M26,25510.9%—
DiagnostykaDIAPoland$1.27B8,64514.9%20.2
DiaSorinDIAItaly$4.21B3,21222.3%28.6
Sonic HealthcareSHLAustralia$7.13B47,0009.3%17.6
WuXi XDC Cayman2268Hong Kong SAR China$9.64B3,62828.1%46.6

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Fleury with its competitors